Senior Advisor
Eli Lilly and Company
Jennifer A Martin, MS is a Senior Advisor in Drug Disposition at Eli Lilly and Company in Indianapolis, Indiana. Jennifer is responsible for the design, analysis, and interpretation of studies for the absorption/distribution/metabolism/excretion (ADME) of peptides and biologics in support of ADME, pharmacology, and toxicology studies. She provides scientific consultation and expertise on cross-functional program teams to design development plans, recommend selection of drug candidates for development, and prepare for worldwide regulatory submissions. She has recently been actively engaged in developing ADME strategies for peptides that fall under either NDA or BLA regulations and has contributed to a cross-industry white paper describing the current practices for assessing the ADME characteristics of therapeutic proteins through the International Consortium for Innovation and Quality (IQ).